New Jersey-based drugmaker Insmed gained more than $3 billion in market value Tuesday after reporting clinical trial results for an...
Medicine
Artificial intelligence (AI) has sparked a revolution in the pharmaceutical industry, reshaping the way we approach complex biological challenges. “From...
BioPharma Dive is testing out a new format rounding up smaller updates from around the industry. Have thoughts on what...
Dive Brief: Shares in Cytokinetics sank by about one-fifth Thursday on news of a funding deal the biotechnology company struck...
Dive Brief: German drugmaker Merck KGaA agreed to buy Mirus Bio for $600 million to build expertise in a critical...
Orna Therapeutics, a young biotechnology company focused on a flashy area of genetic research, is expanding through the acquisition of...
Eli Lilly plans to spend another $5.3 billion building production capacity for its popular obesity and diabetes drugs, responding to...
A top Food and Drug Administration official on Friday again advocated for the speedy approval of gene therapies for rare...
BioPharma Dive is testing out a new format rounding up smaller updates from around the industry. Have thoughts on what...
An older form of hormone therapy taken to ease the symptoms of menopause could increase the risk of ovarian cancer,...